Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CHH NYSE:KSS NASDAQ:TGTX NASDAQ:UPST On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHHChoice Hotels International$110.53+0.7%$109.62$84.04▼$136.45$5.03B0.67668,144 shs130,438 shsKSSKohl's$16.81+0.0%$15.54$9.19▼$25.22$1.90B1.44.81 million shs820,448 shsTGTXTG Therapeutics$55.26-3.2%$46.18$25.28▼$59.30$8.46B1.62.21 million shs738,351 shsUPSTUpstart$32.20-1.7%$31.33$23.97▼$87.30$3.08B2.264.87 million shs873,064 shs7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHHChoice Hotels International0.00%-2.69%+0.26%-4.81%-18.16%KSSKohl's0.00%-8.39%-7.01%+24.28%+74.83%TGTXTG Therapeutics0.00%+7.15%+15.35%+69.04%+54.05%UPSTUpstart0.00%-5.87%+7.34%+16.68%-56.70%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHHChoice Hotels International$110.53+0.7%$109.62$84.04▼$136.45$5.03B0.67668,144 shs130,438 shsKSSKohl's$16.81+0.0%$15.54$9.19▼$25.22$1.90B1.44.81 million shs820,448 shsTGTXTG Therapeutics$55.26-3.2%$46.18$25.28▼$59.30$8.46B1.62.21 million shs738,351 shsUPSTUpstart$32.20-1.7%$31.33$23.97▼$87.30$3.08B2.264.87 million shs873,064 shs7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHHChoice Hotels International0.00%-2.69%+0.26%-4.81%-18.16%KSSKohl's0.00%-8.39%-7.01%+24.28%+74.83%TGTXTG Therapeutics0.00%+7.15%+15.35%+69.04%+54.05%UPSTUpstart0.00%-5.87%+7.34%+16.68%-56.70%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHHChoice Hotels International 1.86Reduce$111.671.03% UpsideKSSKohl's 1.63Reduce$15.31-8.91% DownsideTGTXTG Therapeutics 2.56Moderate Buy$53.33-3.49% DownsideUPSTUpstart 2.24Hold$45.2040.39% UpsideCurrent Analyst Ratings BreakdownLatest CHH, TGTX, KSS, and UPST Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/13/2026TGTXTG Therapeutics HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$70.00 ➝ $77.007/9/2026UPSTUpstart The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$32.00 ➝ $39.007/7/2026CHHChoice Hotels International Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)7/7/2026TGTXTG Therapeutics Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetUnderperform$17.00 ➝ $20.007/7/2026UPSTUpstart BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$43.007/7/2026UPSTUpstart Needham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$37.00 ➝ $40.007/6/2026KSSKohl's Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingUnderweight$15.007/6/2026TGTXTG Therapeutics HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$70.006/22/2026TGTXTG Therapeutics Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$83.006/15/2026KSSKohl's Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold6/15/2026UPSTUpstart Needham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$37.00(Data available from 7/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHHChoice Hotels International$1.60B3.13$9.51 per share11.62$3.92 per share28.20KSSKohl's$15.46B0.12$7.89 per share2.13$36.08 per share0.47TGTXTG Therapeutics$616.29M13.73$2.71 per share20.39$4.08 per share13.55UPSTUpstart$1.12B2.75$0.79 per share40.61$8.21 per share3.92Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHHChoice Hotels International$369.95M$7.4214.9014.265.2521.55%281.98%10.90%8/5/2026 (Estimated)KSSKohl's$272M$2.367.1212.00N/A1.76%4.67%1.38%8/26/2026 (Estimated)TGTXTG Therapeutics$447.18M$2.8619.3219.121.3865.95%88.73%43.44%8/3/2026 (Estimated)UPSTUpstart$53.60M$0.3884.7118.940.864.34%5.63%1.49%8/4/2026 (Estimated)Latest CHH, TGTX, KSS, and UPST EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2026Q2 2026CHHChoice Hotels International$1.95N/AN/AN/A$430.09 millionN/A8/4/2026Q2 2026UPSTUpstart$0.55N/AN/AN/A$348.73 millionN/A8/3/2026Q2 2026TGTXTG Therapeutics$0.44N/AN/AN/A$228.85 millionN/A5/28/2026Q1 2027KSSKohl's-$0.18-$0.13+$0.05-$0.13$2.99 billion$3.17 billion5/6/2026Q1 2026TGTXTG Therapeutics$0.23$0.12-$0.11$0.12$200.33 million$204.92 million5/5/2026Q1 2026UPSTUpstart$0.39-$0.07-$0.46-$0.07$301.30 million$308.21 million4/30/2026Q1 2026CHHChoice Hotels International$1.35$1.07-$0.28$0.44$333.48 million$340.58 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCHHChoice Hotels International$1.151.04%+37.97%15.50%N/AKSSKohl's$0.502.98%-6.51%21.19%N/ATGTXTG TherapeuticsN/AN/AN/AN/AN/AUPSTUpstartN/AN/AN/AN/AN/ALatest CHH, TGTX, KSS, and UPST DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/20/2026CHHChoice Hotels Internationalquarterly$0.28751.05%7/1/20267/1/20267/15/20265/20/2026KSSKohl'squarterly$0.12503.14%6/10/20266/10/20266/24/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHHChoice Hotels International14.580.950.95KSSKohl's0.931.480.31TGTXTG Therapeutics1.285.815.12UPSTUpstartN/A0.490.49Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHHChoice Hotels International65.57%KSSKohl's98.04%TGTXTG Therapeutics58.58%UPSTUpstart63.01%Insider OwnershipCompanyInsider OwnershipCHHChoice Hotels International23.78%KSSKohl's1.55%TGTXTG Therapeutics8.87%UPSTUpstart17.29%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCHHChoice Hotels International1,70045.50 million34.64 millionOptionableKSSKohl's84,000113.40 million111.64 millionOptionableTGTXTG Therapeutics290153.08 million139.51 millionOptionableUPSTUpstart1,40595.71 million79.16 millionOptionableCHH, TGTX, KSS, and UPST HeadlinesRecent News About These CompaniesUpstart Holdings (UPST) Renews $600M Forward-Flow AgreementJuly 11 at 12:50 PM | finance.yahoo.comUpstart Holdings Inc (UPST) Stock Up 4.5% and Still Undervalued -- GF Score: 61/100July 9, 2026 | gurufocus.comUpstart Holdings, Inc. (UPST) Registers a Bigger Fall Than the Market: Important Facts to NoteJuly 8, 2026 | finance.yahoo.comUpstart Holdings, Inc. (UPST) Registers a Bigger Fall Than the Market: Important Facts to NoteJuly 8, 2026 | zacks.comUpstart Holdings, Inc. (UPST) Is a Trending Stock: Facts to Know Before Betting on ItJuly 8, 2026 | finance.yahoo.comUpstart Holdings, Inc. (UPST) Is a Trending Stock: Facts to Know Before Betting on ItJuly 8, 2026 | zacks.comUpstart Holdings (UPST) Could Be 15% Undervalued After Bullish BreakoutJuly 7, 2026 | finance.yahoo.comUpstart Holdings, Inc. $UPST is Halter Ferguson Financial Inc.'s 3rd Largest PositionJuly 7, 2026 | marketbeat.comUpstart (NASDAQ:UPST) Given New $40.00 Price Target at Needham & Company LLCJuly 7, 2026 | americanbankingnews.comUpstart (NASDAQ:UPST) Given "Buy" Rating at BTIG ResearchJuly 7, 2026 | americanbankingnews.comUpstart Stock Analysis: Buy or Sell This AI Stock?July 7, 2026 | fool.comUpstart stock soars 20% on strong Q4 revenue, upbeat 2025 outlookJuly 6, 2026 | msn.comUpstart to Announce Second Quarter 2026 Results on August 4, 2026July 6, 2026 | businesswire.comFintech Stocks in Focus as AI and Digital Payments Reshape FinanceJuly 6, 2026 | zacks.comUpstart Publishes June 2026 Origination VolumeJuly 6, 2026 | businesswire.comUpstart (NASDAQ:UPST) versus Inter & Co. Inc. (NASDAQ:INTR) Head-To-Head SurveyJuly 4, 2026 | americanbankingnews.comUpstart Holdings, Inc. (NASDAQ:UPST) Receives Average Rating of "Hold" from AnalystsJuly 4, 2026 | americanbankingnews.comUpstart: Promising Recovery Set Up Despite Potentially Lumpy Q2 2026; Reiterate BuyJuly 3, 2026 | seekingalpha.comUpstart Holdings, Inc. (UPST) Stock Moves -2.69%: What You Should KnowJuly 2, 2026 | finance.yahoo.comUpstart Stock Outlook Hinges on Funding, AI and Product MixJuly 2, 2026 | zacks.comUpstart and the Lending Trends Shaping Its Next Growth PhaseJuly 2, 2026 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCHH, TGTX, KSS, and UPST Company DescriptionsChoice Hotels International NYSE:CHH$110.52 +0.81 (+0.73%) As of 12:01 PM Eastern This is a fair market value price provided by Massive. Learn more.Choice Hotels International, Inc., together with its subsidiaries, operates as a hotel franchisor in the United States and internationally. It operates through Hotel Franchising & Management and Corporate & Other segments. The company franchises lodging properties under the brand names of Comfort Inn, Comfort Suites, Quality, Clarion, Clarion Pointe, Sleep Inn, Ascend Hotel Collection, Econo Lodge, Rodeway Inn, MainStay Suites, Suburban Studios, WoodSpring Suites, Everhome Suites, Cambria Hotels, Radisson Blu, Radisson RED, Radisson, Park Plaza, Country Inn & Suites by Radisson, Radisson Inn & Suites, Park Inn by Radisson, Radisson Individuals, and Radisson Collection. Choice Hotels International, Inc. was founded in 1939 and is headquartered in North Bethesda, Maryland.Kohl's NYSE:KSS$16.80 +0.01 (+0.03%) As of 12:02 PM Eastern This is a fair market value price provided by Massive. Learn more.Kohl's Corporation operates as an omnichannel retailer in the United States. It offers branded apparel, footwear, accessories, beauty, and home products through its stores and website. The company provides its products primarily under the brand names of Croft & Barrow, Jumping Beans, SO, Sonoma Goods for Life, and Tek Gear, as well as Food Network, LC Lauren Conrad, Nine West, and Simply Vera Vera Wang. Kohl's Corporation was founded in 1988 and is headquartered in Menomonee Falls, Wisconsin.TG Therapeutics NASDAQ:TGTX$55.26 -1.86 (-3.25%) As of 12:02 PM Eastern This is a fair market value price provided by Massive. Learn more.TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Umbralisib, an oral inhibitor of PI3K-delta inhibitor for the treatment of adult patients with relapsed or refractory marginal zone lymphoma and follicular lymphoma; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; Rhizen Pharmaceuticals, S A. for the development and commercialization of umbralisib; Jiangsu Hengrui Medicine Co.; and Novimmune SA, as well as collaboration agreement with Checkpoint Therapeutics, Inc. for the development and commercialization of anti-PD-L1 and anti-GITR antibody research programs in the field of hematological malignancies. TG Therapeutics, Inc. was incorporated in 1993 and is based in Morrisville, North Carolina.Upstart NASDAQ:UPST$32.20 -0.55 (-1.66%) As of 12:02 PM Eastern This is a fair market value price provided by Massive. Learn more.Upstart Holdings, Inc., together with its subsidiaries, operates a cloud-based artificial intelligence (AI) lending platform in the United States. Its platform includes personal loans, automotive retail and refinance loans, home equity lines of credit, and small dollar loans that connects consumer demand for loans to its to bank and credit unions. Upstart Holdings, Inc. was founded in 2012 and is headquartered in San Mateo, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why Micron Is Doubling Down While the HBM Shortage Persists AMD's 5C Deal Positions It as a Direct NVIDIA Rival China's Helium Ban Could Reshape the AI Supply Chain Analysts See Major Upside for These 5 Stocks MarketBeat Week in Review – 07/06 - 07/10 3 Overlooked Stocks Positioned for the Next Market Rotation Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing Why WD-40 Is Proving Great Businesses Never Go Out of Style Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
